BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Analysis of Colorectal Cancer R&D The Complete Guide

"Analysis of Colorectal Cancer R&D - the Complete Guide" offers a unique tool for analysing the vast amount of strategic possibilities that have emerged in colorectal cancer R&D. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. This tool provides you with an immense amount of information structured and analysed to assist you in your work. Additionally, BioSeeker has developed a CD-ROM searchable database, which is continuously updated to reflect the most recent advances in the field of colorectal cancer development, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for your own specific purposes.  

Our hope is that this product will assist you in your struggle of finding the right partners, optimising your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available. 

For your convenience, information about new innovative cancer therapies such as antisense, monoclonal antibodies, gene therapy, antigen- or cellular-based vaccines, liposomal hormones and apoptotic drugs are analysed in more than 100 extensive tables and graphs. "Analysis of Colorectal Cancer R&D - the Complete Guide" gives you easy-to-read tables with projects classified into well-defined structures based on type of therapy given, effect and mechanism. The graphs provide all the relations of these factors as well as the general and specific trends in the current colorectal cancer pipeline.  

Included in this advantageous package are two products already appreciated by many of our customers representing a value of almost $5000 - the Global Structure of Colorectal Cancer R&D and the Colorectal Cancer R&D Database.  

The package includes:  

Information on more than 160 companies active in colorectal cancer R&D

Information on more than 340 industry related colorectal cancer projects

Data from more than 220 clinical trials

Information on 105 preclinical projects

Over 90 graphs illustrating the most important relations between types of therapy, effects and mechanisms

Advanced analysis of general and specific trends in the pipeline

Possibility of performing advanced searches suited to your individual needs

Taking these searches a step further by generating specific and relevant tables and graphs for optimised support in your decision-making process

A significant advantage with BioSeeker Group CD-ROM searchable databases is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeeker Group CD-ROM searchable databases give better overview and specific search capabilities.  

Format: CD-ROM

Published: March 2004 

Publisher: BioSeeker 

To order go to this URL: http://www.bioportfolio.com/cgi-bin/acatalog/BioSeeker.html#a77


 

 

 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.